ARCHIVES

Capitol Hill: Senate bill would allow sale of therapies for catastrophic illness after phase I trials.

This article is from The Cancer Letter archive.

Vol. 31 No. 44 | December 2, 2005

Download PDF Visit The Full Archive

Related Articles

NCI, NEI Announce Interest In Grants On Ocular, Melanoma

November 21, 1980

NCI Board of Scientific Advisors rejects the Institute’s $89 million proteomics research plan.

March 11, 2005

R01 and P01 Grants Will No Longer Support Phase III Clinical Trials

July 25, 2013

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

NS Sponsors Workshop On Prevention For Three Minority Groups

July 1, 1988

New Grant Program in Physical Activity

March 28, 2003